Comparison of efficacy and toxicity profiles between paclitaxel/lobapoatin‐ and cisplatin/5‐fluorouracil‐based concurrent chemoradiotherapy of advanced inoperable oesophageal cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|7|757-761

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.7, 2015-07, pp. : 757-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concurrent Chemoradiotherapy with Low-Dose Cisplatin plus 5-Fluorouracil for the Treatment of Patients with Unresectable Head and Neck Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 10, 2015-10 ,pp. : 1638-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1638-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Locoregionally Advanced Nasopharyngeal Carcinoma: Induction Chemotherapy with Cisplatin and 5-Fluorouracil Followed by Radiotherapy and Concurrent Cisplatin

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 158-166

Karger

Access to resources Recommend Favorite

Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 101-108

Karger

Access to resources Recommend Favorite